The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function

被引:68
作者
Zuppa, AF
Nadkarni, V
Davis, L
Adamson, PC
Helfaer, MA
Elliott, MR
Abrams, J
Durbin, D
机构
[1] Childrens Hosp Philadelphia, Dept Anesthesia & Crit Care Med, Div Crit Care Med, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
关键词
pediatric; thyroid hormone; vasopressor; brain death;
D O I
10.1097/01.CCM.0000146133.52982.17
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. To determine the impact of a thyroid hormone infusion (T4) on the vasopressor requirements in children with cessation of neurologic function (i.e., brain death) during evaluation for organ recovery Design: Retrospective cohort study. Setting. The 1998-2002 database of a regional organ recovery program. Patients. Children less than or equal to18 yrs with cessation of neurologic function during evaluation for organ recovery (n = 171) were included. The treated group (n = 91) received a weight-based bolus and continuous infusion of T4 according to the organ procurement agency protocol. All other children (n = 80) were considered untreated. Interventions: T4 was administered at the clinician's discretion. All children (treated and untreated) had identical goals for fluids, blood pressure, and organ function criteria. Vasopressor score ([dopamine x 1] + [dobutamine x 1] + [epinephrine x 100] + [norepinephrine x 100] + [phenylephrine x 100]) at the time of the program's involvement (T-O) and at organ recovery (T-OR) were recorded. The Wilcoxon rank sum and Student's two-samplet-test were used to compare the average vasopressor score at T-O vs. T-OR. The Wilcoxon signed rank test was used to analyze the difference in median vasopressor score at T-O vs. T-OR. Multivariable linear regression was used to assess the impact of T4 on the ability to wean vasopressor support while accounting for the effects of several potential confounders. Measurements and Main Results: One hundred seventy-one subjects were included in the final analysis. T4 administration was associated with an unadjusted decrease in the vasopressor score of 32 (95% confidence interval, 12-53; p =.002). After adjusting for steroid administration, fluid balance, and baseline vasopressor score, T4 administration was associated with a decrease in vasopressor score of 24 (95% confidence interval, 6-43; P =.011). Conclusions: T4 reduced vasopressor needs in children with cessatIon of neurologic function and hemodynamic instability. A prospective study of T4 in critically ill and hemodynamically unstable children appears warranted.
引用
收藏
页码:2318 / 2322
页数:5
相关论文
共 20 条
[1]   Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery - A randomized, double-blind, placebo-controlled trial [J].
BennettGuerrero, E ;
Jimenez, JL ;
White, WD ;
DAmico, EB ;
Baldwin, BI ;
Schwinn, DA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (09) :687-692
[2]   Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study [J].
Bettendorf, M ;
Schmidt, KG ;
Grulich-Henn, J ;
Ulmer, HE ;
Heinrich, UE .
LANCET, 2000, 356 (9229) :529-534
[3]   Clinical review 86 - Euthyroid sick syndrome: Is it a misnomer? [J].
Chopra, IJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :329-334
[4]   Dangerous dogmas in medicine: The nonthyroidal illness syndrome [J].
De Groot, LJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :151-164
[5]   Improving the approach to organ donation: A review [J].
Jenkins, DH ;
Reilly, PRM ;
Schwab, CW .
WORLD JOURNAL OF SURGERY, 1999, 23 (07) :644-649
[6]   THYROID-HORMONE TREATMENT AFTER CORONARY-ARTERY BYPASS-SURGERY [J].
KLEMPERER, JD ;
KLEIN, I ;
GOMEZ, M ;
HELM, RE ;
OJAMAA, K ;
THOMAS, SJ ;
ISOM, OW ;
KRIEGER, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1522-1527
[7]   Effect of acute high dose dobutamine administration on serum thyrotrophin (TSH) [J].
Lee, E ;
Chen, PJ ;
Rao, H ;
Lee, J ;
Burmeister, LA .
CLINICAL ENDOCRINOLOGY, 1999, 50 (04) :487-492
[8]   Hormones in the critically ill patient: to intervene or not to intervene? [J].
Ligtenberg, JJM ;
Girbes, ARJ ;
Beentjes, JAM ;
Tulleken, JE ;
van der Werf, TS ;
Zijlstra, JG .
INTENSIVE CARE MEDICINE, 2001, 27 (10) :1567-1577
[9]   REDUCTION IN TRIIODOTHYRONINE LEVELS FOLLOWING MODIFIED FONTAN PROCEDURE [J].
MAINWARING, RD ;
LAMBERTI, JJ ;
CARTER, TL ;
NELSON, JC .
JOURNAL OF CARDIAC SURGERY, 1994, 9 (03) :322-331
[10]   Reduction in levels of triidothyronine following the first stage of the Norwood reconstruction for hypoplastic left heart syndrome [J].
Mainwaring, RD ;
Healy, RM ;
Meier, FA ;
Nelson, JC ;
Norwood, WI .
CARDIOLOGY IN THE YOUNG, 2001, 11 (03) :295-300